healthy adult
Conditions
Interventions
Test Food A (2 capsules once a day)
Test Food B (2 capsules once a day)
Placebo Food (Food C) (2 capsules once a day)
Sponsors
Clinical Creative Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Age: 40 years old or older and under 75 years old (at the time of obtaining consent) 2.Gender: male and female 3.Inpatient and outpatient services: outpatient 4. Healthy Japanese who are experiencing memory decline 5.Those with relatively low CogEvo scores Those who score between 22 and 27 on the Mini Mental State Examination (MMSE)
Exclusion criteria
Exclusion criteria: 1.Persons taking medication for treatment of diseases (arrhythmia, liver damage, kidney damage, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension and other chronic diseases) 2.Patients with malignancy, heart failure, or myocardial infarction, or who are undergoing treatment or have a history of such treatment 3.A person suffering from dementia 4.Those suffering from mental illnesses such as depression or attention deficit/hyperactivity disorder (ADHD) 5.Persons with allergies (pharmaceuticals and test foods) 6.Those who regularly consume foods or supplements that contribute to improving cognitive function, such as DHA, EPA, Ginkgo biloba extract, tocotrienol, astaxanthin, GABA, phosphatidylserine, lutein, zeaxanthin, imidazole dipeptides (carnosine, enserine, valenine), histidine, curcumin, bacopa saponin, lactonadecapeptide, anthocyanin, seryl tyrosine, auraptene, and diosgenin. 7.Persons who regularly consume pharmaceuticals (including herbal medicines), food for specified health uses, functional foods, or other foods/beverages with possible functional properties. 8.A person who has participated in another clinical trial within one month prior to obtaining consent or who is currently participating in another clinical trial. Those who, in the judgment of the principal investigator or sub-investigator, the conduct of the study may increase the risk to research subjects or may not provide sufficient data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CogEvo | — |
Secondary
| Measure | Time frame |
|---|---|
| Mini Mental State Examination | — |
Countries
Japan
Contacts
Public ContactKazuhiro Ohno
Clinical Creative Corporation Pharmaceutical Development Division
Outcome results
None listed